Early Glycemic Control May Improve CV Outcomes in Patients With T2D
Early control of glycated hemoglobin (HbA1c) may improve cardiovascular outcomes in type 2 diabetes.
Early control of glycated hemoglobin (HbA1c) may improve cardiovascular outcomes in type 2 diabetes.
Investigators at the San Francisco Veterans Affairs (VA) Health Care System evaluated VA health records between February 2020 and November 2021.
The associations between exposure to abuse in childhood and risk factors for incident cardiovascular disease vary by race and sex.
For individuals with type 2 diabetes, subjective cognitive impairment (SCI) is associated with cardiovascular events.
People with serious mental illness (SMI), particularly schizophrenia, have higher levels of cardiovascular disease (CVD)-related mortality and a higher incidence of CVD than the general population.
Cardiovascular risk factors are associated with an increased risk for depression in older adults.
Presenting at the 2022 AAN Annual Meeting, researchers evaluated the overall cardiovascular burden among adult patients with narcolepsy.
For patients with established atherosclerotic cardiovascular disease, the treatment benefit of smoking cessation is equivalent to the use of targeted pharmaceutical interventions in persistent smokers.
Researchers examined the role of exercise in decreasing cardiovascular risk in patients with anxiety and depression.
Childhood risk factors are associated with cardiovascular events in midlife.